January 29, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS), a medical technology innovator specializing in rapid, non-invasive testing, announced that Quantum Traffic Management (“Quantum TM”), a prominent UK traffic management company, has implemented INBS’ Intelligent Fingerprinting Drug Testing Solution across its 10 UK locations to enhance workplace safety and testing efficiency.

With more than three decades of expertise, Quantum TM serves industries such as utilities, highways, rail, local government, and events. Previously reliant on external saliva and urine testing, Quantum TM faced delays and inefficiencies. Seeking a faster, more hygienic solution, the company adopted INBS’ fingerprint sweat-based system, enabling in-house, on-site drug screening for faster decision-making and streamlined operations.

“The Intelligent Fingerprinting Drug Testing Solution has transformed our approach to workplace drug testing,” said Scott Powell, Managing Director at Quantum TM. “By replacing outdated saliva and urine testing methods, we’ve gained greater control and significantly boosted testing efficiency with rapid, non-invasive screening.”

INBS’ fingerprint-based system allows organizations to perform accurate drug tests without specialized staff or facilities, overcoming the limitations of traditional methods. With over 400 clients across 19 countries, INBS is driving innovation in drug screening for sectors like construction, manufacturing, transport, and logistics. Following its FDA 510(k) submission in December 2024, INBS is set to expand into the US market in 2025, capitalizing on the growing global demand for point-of-care drug testing.